SB 222, as amended, Padilla. Genetic information: privacy.
Existing law prohibits discrimination on the basis of an individual’s genetic information. Existing law protects the genetic test result contained in the medical records of an applicant to, or enrollee of, a health care service plan. Existing law establishes civil and criminal penalties for the negligent or willful disclosure of a persons genetic test results, as specified.
This bill would enact the Genetic Information Privacy Act, which would declare that an individual’s genetic information is protected by the right of privacy. The bill would prohibit any person frombegin delete collecting, storing, analyzing, or disclosing genetic informationend deletebegin insert obtaining or analyzing a DNA sample, as
defined,end insert without the written authorization of the individual to whom thebegin delete informationend deletebegin insert DNA sampleend insert pertains, and would include related findings and declarations. It also would prescribe specific circumstances under whichbegin delete genetic
informationend deletebegin insert a DNA sampleend insert may bebegin delete collected,end deletebegin insert obtained,end insert stored,begin insert orend insert analyzed, orbegin insert genetic test resultsend insert disclosedbegin insert,end insert without the authorization. The bill would establish civil and criminal penalties for a violation of its provisions. By creating new crimes, this bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: yes.
The people of the State of California do enact as follows:
The Legislature finds and declares all of the
2following:
3(a) On October 11, 2012, the Presidential Commission for the
4Study of Bioethical Issues (commission) released a report titled
5“Privacy and Progress in Whole Genome Sequencing,”
6recommending thebegin delete adoptionsend deletebegin insert adoptionend insert of policies to help ensure
7privacy and security, as the field of genomics advances.
8(b) Various national and state policies are in place tobegin delete protect begin insert
effectively
9personally identifiable health information and records.end delete
10protect individually identifiable health information, biosamples
11used in academic research end insertbegin insertand records, including genetic
12information.end insert
13(c) The commission urges federal and state governments to
14ensure
a consistent floor of privacy protections covering whole
15genome sequencing data regardless of how they were obtained.
16(d)
end delete
17begin insert(c)end insert Policies should protect individual genetic information by
18prohibiting the unauthorized use of surreptitious collection.
19(d) It is the intent of the Legislature to enact legislation to extend
20established protections to individually identifiable genetic
21information not covered by existing national or state policies.
22(e) It is the intent of
the Legislature to enact legislation that
23would protect individuals from the unauthorized collectionbegin delete, storage, begin insert and analysis of their
24and disclosure of their genetic information.end delete
25DNA samples and genetic characteristics.end insert
26(f) It is the intent of the Legislature to enact legislation that
27would ensure that genetic information is personal information that
P3 1is not collected, stored, or disclosed without the individual’s
2authorization.
3(g) It is the intent of the Legislature
to enact legislation that
4would provide protections for the collection, storage, and
5authorized use of genetic information.
6(h)
end delete
7begin insert(f)end insert It is the intent of the Legislature to enact legislation that
8would promote the use of genetic information for legitimate
9reasons, including, but not limited to, health care, research,
10advancement of medicine, and educational purposes, as the field
11of genomics advances.
Chapter 2.6 (commencing with Section 56.18) is added
13to Part 2.6 of Division 1 of the Civil Code, to read:
14
(a) This chapter shall be known, and may be cited, as
18the Genetic Information Privacy Act.
19(b) For purposes of this chapter, the following definitions apply:
20(1) “Deidentified data” is health information that does not
21identify an individual, with respect to which there is no reasonable
22basis to believe that the information can be used to identify an
23individualbegin insert, in accordance with Section 164.514 of Title 45 of the
24Code of Federal Regulationsend insert.
25(2) “DNA sample”
meansbegin delete a tissue, fluid, or other bodily sample begin insert
aend insert
26of an individual on which a DNA analysis can be carried out.end delete
27begin insert human biological specimen that is obtained or retained for the
28purpose of extracting and analyzing DNA to perform a genetic
29test.end insert
30(3) “Genetic characteristic”begin delete means any gene or chromosome, begin insert includes
31or alteration thereof, that may be tested to determine the existence
32or risk of a disease, disorder, trait, propensity, or syndrome, or to
33identify an individual or a blood relative, or to establish or disprove
34paternity, or to achieve other non-health-related purposes.end delete
35a gene, chromosome, or alteration thereof that may be tested to
36determine
the existence or risk of a disease, disorder, trait,
37propensity, or syndrome, or to identify an individual or a blood
38relative.end insert
39(4) (A) “Genetic information” means information about any of
40the following:
P4 1(i) An individual’s genetic tests.
2(ii) The genetic tests of that individual’s family members.
3(iii) The manifestation of disease or disorder in family members
4of the individual, generally referred to as family medical history.
5(iv) An individual’s request for, or receipt of, genetic services,
6or the participation in clinical research that includes genetic
7services by the individual or a family member of the individual.
8(v) The genetic information of a fetus carried by an individual
9or by a pregnant woman who is a family member of the individual
10and the genetic information of any embryo legally held by the
11individual
or family member using an assisted reproductive
12technology.
13(B) “Genetic information” also includes a DNA sample.
14(5) “Genetic service” means a genetic test, genetic education,
15or genetic counseling, including obtaining, interpreting, or
16assessing
genetic information.
17(6)
end delete
18begin insert(4)end insert “Genetic test” means a test for determining the presence or
19absence of genetic characteristics in the individual or in the
20individual’s blood relatives, including tests of nucleic acids such
21as DNA, RNA, and mitochondrial DNA, chromosomes, or proteins,
22in order to diagnose or determine a genetic characteristic.
23(7)
end delete
24begin insert(5)end insert “Person”
means a natural person, trust or estate, partnership,
25corporation, limited liability company, professional association or
26corporation, or other entity, public or private.
(a) Geneticbegin insert testend insert information is protected by the right
28of privacy pursuant to Section 1 of Article I of the California
29begin delete Constitution and, notwithstanding subdivision (c) of Section 56.10, begin insert Constitution. A DNA sample shall
30or any other law, shall not be collected, stored, analyzed, or
31disclosed without the written authorization of the individual to
32whom the information pertains.end delete
33not be obtained or analyzed without the written authorization of
34the individual to whom the DNA sample
pertains.end insert
35(b) begin deleteAny end deletebegin insertA end insertperson who negligently violates subdivision (a) shall
36be assessed a civil penalty in an amount not to exceed one thousand
37dollars ($1,000) plus court costs, as determined by the court, which
38penalty and costs shall be paid to the individual to whom the
39begin deletegenetic information end deletebegin insertDNA sample end insertpertains.
P5 1(c) begin deleteAny end deletebegin insertA
end insertperson who willfully violates subdivision (a) shall
2be assessed a civil penalty in an amount not less than one thousand
3dollars ($1,000) and not more than five thousand dollars ($5,000)
4plus court costs, as determined by the court, which penalty and
5costs shall be paid to the individual to whom thebegin delete genetic begin insert
DNA sampleend insert pertains.
6informationend delete
7(d) begin deleteAny end deletebegin insertA end insertperson who willfully or negligently violates
8subdivision (a),begin delete whereend deletebegin insert andend insert the violation results in economic, bodily,
9or emotional harm to the individual to whom thebegin delete genetic begin insert DNA sampleend insert pertains, is guilty of a misdemeanor
10informationend delete
11punishable by a fine not to exceed ten thousand
dollars ($10,000).
12(e) In addition to the penalties listed in subdivisions (b) and (c),
13a person who commits an act described in subdivision (b) or (c)
14shall be liable to the person to whom thebegin delete genetic informationend deletebegin insert DNA
15samplend insertbegin inserte end insertpertains for all actual damages, including damages for
16economic, bodily, and emotional harm that is proximately caused
17by that act.
18(f) Each violation of this section is a separate and actionable
19offense.
20(g) A laboratory that performs a genetic test shall be deemed
21in compliance with subdivision (a) if the laboratory believes, in
22good faith and in the absence of knowledge to the contrary, that
23a written consent by the individual to whom the DNA sample
24pertains is valid.
25(g) (1) Any
end delete
26begin insert(h)end insertbegin insert end insertbegin insertExcept as provided in subdivision (i), aend insert person or entity that
27wishes to obtainbegin delete genetic information, other than a person or entity begin insert
or analyze a DNA sample, shall obtain a valid
28authorized to receive genetic information pursuant to subdivision
29(h), shall obtain a valid authorization for the release of that
30information.end delete
31authorization from the individual to whom the DNA sample
32pertains.end insert The written authorization required by this subdivision
33shall do all of the following:
34(A)
end delete
35begin insert(1)end insert Be written in plain language and in a typeface no smaller
36than 14-point type.
37(B)
end delete
38begin insert(2)end insert Be dated and signed by the individual or a person authorized
39to act on behalf of the individual.
40(C)
end delete
P6 1begin insert(3)end insert Specify the types of persons authorized tobegin delete disclose begin insert obtain a DNA sample and analyze and disclose the
2informationend delete
3genetic testend insertbegin insert resultsend insert about the individual.
4(D)
end delete
5begin insert(4)end insert Specify the nature of thebegin delete information authorized to be begin insert
genetic test results authorized to be obtained and
6disclosed.end delete
7analyzed.end insert
8(E)
end delete
9begin insert(5)end insert State the name or functions of the persons or entities
10authorized to receive thebegin delete information.end deletebegin insert
genetic test results.end insert
11(F)
end delete
12begin insert(6)end insert Specify the purposes for which thebegin delete informationend deletebegin insert DNA sampleend insert
13 is being collected.
14(G)
end delete
15begin insert(7)end insert Specify the length of time the authorization shall remain
16valid.
17(H)
end delete
18begin insert(8)end insert Advise the person signing the authorization of his or her
19right to control the use of his or herbegin delete genetic informationend deletebegin insert DNA
20sample and test resultsend insert.
21(I) Advise the person signing the authorization of his or her
22right to revoke authorization at any time.
23(J) Advise the person signing the authorization as to whether
24his or her information will remain identifiable or whether measures
25will be taken to make the information nonidentifiable.
26(K)
end delete
27begin insert(9)end insert Advise the person signing the authorization that the genetic
28begin delete informationend deletebegin insert test resultsend insert and begin insertDNA end insertsample provided must be
29destroyed upon achieving that purpose.
30(L)
end delete
31begin insert(10)end insert Advise the person signing the authorization of the right to
32receive a copy of the authorization.begin insert Written authorization is
33required for each separate disclosure of the genetic test results.end insert
34(2)
end delete
35begin insert(i)end insert Any person who collects, stores, begin insertor end insertanalyzesbegin insert the DNA sampleend insert,
36or discloses the geneticbegin delete informationend deletebegin insert
test results,end insert of an individual
37shall comply with all of the following:
38(A)
end delete
39begin insert(1)end insert The person may not collect, store, begin insertor end insertanalyzebegin insert the DNA
40sampleend insert, or disclose the geneticbegin delete informationend deletebegin insert test resultsend insert for any
P7 1
purpose other than the purpose authorized by the individual to
2whom thebegin delete information pertains.end deletebegin insert DNA sample or genetic test results
3pertain.end insert
4(B)
end delete
5begin insert(2)end insert Once the specific purpose authorized by the individual to
6whom the geneticbegin delete information pertainsend deletebegin insert test results pertainend insert has
been
7fulfilled, the individual’s geneticbegin delete informationend deletebegin insert
test resultsend insert and DNA
8sample shall be destroyed.
9(C)
end delete
10begin insert(3)end insert The person shall permit an individual to revoke an
11authorization signed pursuant tobegin delete paragraph (1)end deletebegin insert subdivision (h)end insert at
12any time.
13(D)
end delete
14begin insert(4)end insert The person shall provide an individual who has signed an
15authorization pursuant tobegin delete paragraph (1)end deletebegin insert subdivision (h)end insert with a copy
16of that authorization upon request.
17(h)
end delete
18begin insert(j)end insert (1) begin deleteGenetic information end deletebegin insertA DNA sample end insertmay bebegin delete collectedend delete
19begin insert
obtainedend insert, stored,begin insert orend insert
analyzed, begin deleteor end deletebegin insertand genetic test results end insertdisclosed
20without the authorization required by subdivisionbegin delete (g)end deletebegin insert (h)end insert, in
21accordance with paragraph (2),begin delete provided that the entity may collect, only for the purposes
22store, analyze, or disclose the informationend delete
23specified. Use for any other purpose is subject to the authorization
24required by subdivision (a).
25(2) begin deleteGenetic information end deletebegin insertA
DNA sample end insertmay bebegin delete collected,end delete
26begin insert
obtained,end insert stored,begin insert orend insert analyzed,begin delete orend deletebegin insert and genetic test results end insert disclosedbegin insert,end insert
27 under this subdivision, as follows:
28(A) By a law enforcement official or correctional officer in the
29execution of his or her official duties consistent with existing law.
30(B) By a hospital, laboratory, or physician carrying out
31court-ordered tests for genetic informationbegin insert,
in the execution of his
32or her official duties consistent with existing lawend insert.
33(C) By a licensed health care professional, as defined in Section
3456.05, in a medical emergency.
35(D) By a coroner or medical examiner, in the execution of his
36or her official duties consistent with existing law.
37(E) For purposes of any screening of a newborn infant required
38by state or federal law.
39(C) By a coroner or medical examiner, in the execution of his
40or her official duties consistent with existing law.
P8 1(D) By a federal, state, or local governmental entity, or
2contractor or designee of that governmental entity in the execution
3of his or her official duties consistent with existing law.
4(F)
end delete5begin insert(E)end insert If the information is in the form of deidentified data.
6(G)
end delete
7begin insert(F)end insert Bybegin delete any person or entity covered by and required to comply any of the following:
8withend delete
9(i) The Health Insurance Portability and Accountability Act of
101996 (Public Law 104-191).
11(ii) Section 56.11 of the Confidentiality of Medical Information
12Act (Part 2.6 (commencing with Section 56)).
13(iii) Section 791.13, 10123.35 or Article 2.6 (commencing with
14Section 10146) of Chapter 1 or Part 2 of Division 2 of the Insurance
15Code.
16(iv) Section 50.25 of Title 21 of the Code of Federal
17Regulations.
18(v) Section 46.116 of Title 28 of the Code of Federal
19Regulations.
20(i) A person or entity covered by and required to comply with
21Section 56.11 of the Confidentiality of Medical Information Act
22(Part 2.6 (commencing with Section 56)).
23(ii) A person or entity covered by and required to comply with
24Section 791.13, 10123.35, or Article 2.6 (commencing with Section
2510146) of Chapter 1 of Part 2 of Division 2 of the Insurance Code.
26(iii) A licensed health care professional or designee of a licensed
27health care professional. “Licensed health care professional”
28means any person licensed or certified pursuant to Division 2
29(commencing with Section 500) of the Business and Professions
30Code, the Osteopathic Initiative Act or the Chiropractic Initiative
31Act, or Division 2.5 (commencing with
Section 1797) of the Health
32and Safety Code.
33(iv) A provider of health care or a designee of a provider of
34health care. “Provider of health care” means a health facility
35licensed pursuant to Division 2 (commencing with Section 1200)
36of the Health and Safety Code.
37(v) A covered entity, business associate, or subcontractor as
38those terms are defined in the federal Health Insurance Portability
39and Accountability Act of 1996 (Public Law 104-191) and its
40implementing regulations.
P9 1(vi) An investigator within an institution, or working in
2collaboration with an institution, that holds an assurance with the
3United States Department of Health and Human Services pursuant
4to Part 46 (commencing with Section 46.101) of Title 45 of the
5Code of Federal Regulations and who obtains informed consent
6or who qualifies for an exemption
from informed consent in the
7method and manner required by those regulations.
8(vii) A pharmaceutical company. “Pharmaceutical company”
9means a company or business, or an agent or representative
10thereof, that manufactures, sells, or distributes pharmaceuticals,
11medications, or prescription drugs pursuant to regulations of the
12federal Food and Drug Administration, and that either obtains
13informed consent, or qualifies for an exemption from informed
14consent in the method and manner required by those regulations.
No reimbursement is required by this act pursuant to
16Section 6 of Article XIII B of the California Constitution because
17the only costs that may be incurred by a local agency or school
18district will be incurred because this act creates a new crime or
19infraction, eliminates a crime or infraction, or changes the penalty
20for a crime or infraction, within the meaning of Section 17556 of
21the Government Code, or changes the definition of a crime within
22the meaning of Section 6 of Article XIII B of the California
23Constitution.
O
95